Noteworthy, new serious adverse event (AE) signals were identified, including hemorrhagic diarrhea (ROR: 3.69), hepatic pain (ROR: 4.20), abnormal hormone levels (ROR: 6.51), and pancreatic failure (ROR: 36.34) in subcutaneous semaglutide, and Dupuytrens contracture (ROR: 46.85) in oral semaglutide
It sits in a peptide therapy guide where research status, sourcing, compounding quality, dosing, and clinician oversight all need extra scrutiny and should help with patient education and clinical context
Combined treatment with IGF-IR inhibitor, PARP inhibitor, and/or platinum may be a strategy to improve the efficacy of cancer therapy [100]
2018;25(10):1286-1291.e3
Vitamin B12 aids in the prevention of brain atrophy and also memory issues